Biotech

All Articles

Sanofi fails MS research study, inflicting one more strike to Denali treaty

.Sanofi has actually stopped a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in a n...

Turnstone gives up 60%, shocks C-suite to extend cash

.Turnstone Biologics is actually reducing its head count through 60% as well as agitating its own C-...

Gilead surrenders on $15M MASH bet after weighing preclinical data

.In a year that has observed an approval and a boating of readouts for metabolic dysfunction-associa...

Texas biotech centers cancer treaty, pins hopes on weight problems

.Alaunos Rehabs is axing an agreement with Precigen, quiting licensing liberties to a tailored T-cel...

Capricor portions a lot more records for DMD treatment after initiating BLA

.Capricor Therapeutics is actually taking a triumph lap for their phase 2 Duchenne muscular dystroph...

FDA locations Kezar lupus test in grip observing 4 person fatalities

.The FDA has positioned Kezar Life Sciences' lupus trial on grip after the biotech hailed 4 deaths d...

Phase 3 Scholar Stone test reaches SMA goal, sending stock up 200%

.A phase 3 trial of Academic Stone's spinal muscle atrophy (SMA) applicant has struck its own primar...

CAMP 4 is most up-to-date to eye IPO, while Upstream spells out $182M program

.RNA biotech CAMP4 Therapeutics has defined think about a $67 million IPO, along with inflammation-f...

Galecto purchases leukemia medication, goes down bone tissue cancer resource in pivot

.A year after the failing of an idiopathic pulmonary fibrosis prospect delivered Galecto on a hunt f...

Judo throws down $100M to knock senseless kidney health condition

.Taking the floor covering is actually Judo Bio, an up-and-coming biotech armed along with $one hund...